Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.
Is Shift Worker Diet An Occupational Hazard?
December 29th, 2011 FAKE NEWS for the Zionist agenda